Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20130719014054N2
IRCT20130719014054N2
Recruiting
Phase 3

The investigation of the efficacy and safety of Empagliflozin in the treatment of heart failure in people who living with HIV/AIDS: Randomized, Clinical Trial study

Tehran University of Medical Sciences0 sites128 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Tehran University of Medical Sciences
Enrollment
128
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Age \>18YEARS

Exclusion Criteria

  • •MALIGNANCY OR Opportunistic infection
  • •CKD AND GFR\<20

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
Exploratory survey of the safety and efficacy of endoscopic radiofrequency ablation for malignant biliary strictureMalignant biliary stricture
JPRN-UMIN000031601Graduate School of Medicine, Chiba University10
Active, not recruiting
Phase 1
A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia - Ezetimibe/Simvastatin and Fenofibrate Coadministration Study
EUCTR2004-003807-19-ESMerck & Co Inc.600
Active, not recruiting
Not Applicable
A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia - Ezetimibe/Simvastatin and Fenofibrate Coadministration StudyMixed hyperlipidemiaMedDRA version: 7.0Level: LLTClassification code 10027762
EUCTR2004-003807-19-ATMerck, Sharp & Dohme600
Active, not recruiting
Phase 1
A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia - Ezetimibe/Simvastatin and Fenofibrate Coadministration StudyMixed hyperlipidemiaMedDRA version: 7.0 Level: LLT Classification code 10027762
EUCTR2004-003807-19-GBMerck Sharp & Dohme Ltd600
Active, not recruiting
Not Applicable
A Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin and Fenofibrate Coadministration in Patients With Mixed Hyperlipidemia - Ezetimibe/Simvastatin and Fenofibrate Coadministration StudyMixed hyperlipidemiaMedDRA version: 7.0Level: LLTClassification code 10027762
EUCTR2004-003807-19-HUMerck & Co., Inc.600